Knocking Out Rap1a Attenuates Cardiac Remodeling and Fibrosis in a Male Murine Model of Angiotensin II-Induced Hypertension
Cells · 2025
DOI: 10.3390/cells14221834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Cody S Porter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677-1848, USA. Hauptthemen laut MEDLINE: Angiotensin II, Hypertension, rap1 GTP-Binding Proteins, Ventricular Remodeling. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Institutional Development Award, University of Mississippi School of Pharmacy and the Department of BioMolecular Sciences.
Abstract (Originalsprache)
Hypertension is a leading risk factor for cardiovascular disease and is associated with maladaptive cardiac remodeling, including hypertrophy and fibrosis. The roles of the receptor for advanced glycation end-products (RAGE) and the small GTPase Rap1a in angiotensin II (AngII)-induced remodeling remain unclear. This study examined how RAGE and Rap1a influence cardiac responses to AngII using wild-type (WT), RAGE knockout (RAGE KO), and Rap1a knockout (RapKO) mice. Cardiac structure and function were evaluated following AngII infusion. RapKO mice were protected from AngII-induced hypertrophy, whereas RAGE KO mice exhibited altered remodeling patterns. AngII consistently increased left ventricular wall thickness across all genotypes, indicating that structural remodeling is primarily treatment-driven. Measures of cardiac output and stroke volume also changed significantly with AngII, suggesting hemodynamic load as a key driver of functional adaptation. In contrast, diastolic functional parameters were genotype-dependent and remained stable with AngII exposure, demonstrating an intrinsic influence of RAGE and Rap1a on myocardial relaxation. These findings highlight distinct roles for RAGE and Rap1a in modulating hypertensive cardiac remodeling and may parallel human hypertensive heart disease, where increased RAGE and Rap1a expression associate with fibrosis and impaired relaxation. Targeting the crosstalk between the RAGE-AT1R axis and the cAMP-EPAC-Rap1a pathway may offer therapeutic potential to reduce adverse cardiac remodeling in hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677-1848, USA.
ORCID-Profile: Mason T Hickel, James A Stewart
Förderung
- NIGMS NIH HHS
- Institutional Development Award
- University of Mississippi School of Pharmacy and the Department of BioMolecular Sciences
Zitieren
APA
Porter, C. S., Brown, L. T., Lacey, C., Hickel, M. T., & Stewart, J. A. (2025). Knocking Out Rap1a Attenuates Cardiac Remodeling and Fibrosis in a Male Murine Model of Angiotensin II-Induced Hypertension. Cells. https://doi.org/10.3390/cells14221834
Vancouver
Porter CS, Brown LT, Lacey C, Hickel MT, Stewart JA. Knocking Out Rap1a Attenuates Cardiac Remodeling and Fibrosis in a Male Murine Model of Angiotensin II-Induced Hypertension. Cells. 2025. doi:10.3390/cells14221834
BibTeX
@article{Porter2025,
author = {Porter, Cody S and Brown, Larissa T and Lacey, Can'Torrius and Hickel, Mason T and Stewart, James A},
title = {Knocking Out Rap1a Attenuates Cardiac Remodeling and Fibrosis in a Male Murine Model of Angiotensin II-Induced Hypertension},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14221834}
}
EUVIMED